Related Experiment Video
Updated: Feb 27, 2026
Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses
Published on: May 6, 2019
Expression Optimization of Anti-CD22 scFv-Apoptin Fusion Protein Using Experimental Design Methodology
Solmaz Agha Amiri1, Najmeh Zarei2, Somayeh Enayati2
1Department of Pharmaceutical Biotechnology, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Background:
Design of experiments is a rapid and cost-effective approach for optimization of recombinant protein production process. In our previous study, we generated a potent dual-acting fusion protein, anti-CD22 scFv-apoptin, to target B-cell malignant cell lines. In the present investigation, we report the effect of different variables on the expression levels of this fusion protein.
Methods:
Four variables (cell optical density at induction, IPTG concentration, induction temperature, and induction time) were tested using experimental design.
Results:
Our findings demonstrated that among the examined variables, only the induction time had a significant positive effect on the protein expression yield.
Conclusion:
Experimental design was successfully applied in this study. The optimized condition obtained in the current study can be applied in future commercial production of this novel fusion protein.
More Related Videos
09:29Clinical Application of Sleeping Beauty and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood
Published on: February 1, 2013
11:58Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
Published on: March 8, 2018